| Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombosis M Xi, L Zhang, L Zhao, QQ Li, SP Guo, ZZ Feng, XW Deng, XY Huang, ... PLoS One 8 (5), e63864, 2013 | 171 | 2013 |
| Intensity-modulated radiation therapy for definitive treatment of cervical cancer: a meta-analysis Y Lin, K Chen, Z Lu, L Zhao, Y Tao, Y Ouyang, X Cao Radiation Oncology 13, 1-8, 2018 | 106 | 2018 |
| Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers Y Wang, Z Li, S Zheng, Y Zhou, L Zhao, H Ye, X Zhao, W Gao, Z Fu, ... Oncotarget 6 (34), 35684, 2015 | 106 | 2015 |
| Long non-coding RNA HOTTIP is correlated with progression and prognosis in tongue squamous cell carcinoma H Zhang, L Zhao, YX Wang, M Xi, SL Liu, LL Luo Tumor Biology 36, 8805-8809, 2015 | 105 | 2015 |
| Clinical efficacy and failure pattern in patients with cervical esophageal cancer treated with definitive chemoradiotherapy P Zhang, M Xi, L Zhao, B Qiu, H Liu, YH Hu, MZ Liu Radiotherapy and Oncology 116 (2), 257-261, 2015 | 83 | 2015 |
| Recurrence patterns after neoadjuvant chemoradiotherapy compared with surgery alone in oesophageal squamous cell carcinoma: results from the multicenter phase III trial … S Liu, J Wen, H Yang, Q Li, Y Chen, C Zhu, W Fang, Z Yu, W Mao, J Xiang, ... European Journal of Cancer 138, 113-121, 2020 | 56 | 2020 |
| Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3 L Zhao, LR He, M Xi, MY Cai, JX Shen, QQ Li, YJ Liao, D Qian, ZZ Feng, ... Journal of translational medicine 10, 1-9, 2012 | 56 | 2012 |
| The modified glasgow prognostic score is an independent prognostic factor in patients with inoperable thoracic esophageal squamous cell carcinoma undergoing chemoradiotherapy P Zhang, M Xi, QQ Li, LR He, SL Liu, L Zhao, JX Shen, MZ Liu Journal of Cancer 5 (8), 689, 2014 | 53 | 2014 |
| Is there a benefit in receiving concurrent chemoradiotherapy for elderly patients with inoperable thoracic esophageal squamous cell carcinoma? P Zhang, M Xi, L Zhao, JX Shen, QQ Li, LR He, SL Liu, MZ Liu PloS one 9 (8), e105270, 2014 | 37 | 2014 |
| Activation of satellite glial cells in trigeminal ganglion following dental injury and inflammation H Liu, L Zhao, W Gu, Q Liu, Z Gao, X Zhu, Z Wu, H He, F Huang, W Fan Journal of molecular histology 49, 257-263, 2018 | 34 | 2018 |
| miR-181a, delivered by hypoxic PTC-secreted exosomes, inhibits DACT2 by downregulating MLL3, leading to YAP-VEGF-mediated angiogenesis Y Wang, A Cen, Y Yang, H Ye, J Li, S Liu, L Zhao Molecular Therapy-Nucleic Acids 24, 610-621, 2021 | 32 | 2021 |
| Is there a correlation between clinical complete response and pathological complete response after neoadjuvant chemoradiotherapy for esophageal squamous cell cancer? SL Liu, M Xi, H Yang, YD Yang, YJ Wu, L Zhao, P Zhang, LL Luo, MZ Liu Annals of surgical oncology 23, 273-281, 2016 | 30 | 2016 |
| Concurrent cisplatin and 5-fluorouracil versus concurrent cisplatin and docetaxel with radiotherapy for esophageal squamous cell carcinoma: a propensity score-matched analysis P Zhang, M Xi, QQ Li, YH Hu, X Guo, L Zhao, H Liu, SL Liu, LL Luo, Q Liu, ... Oncotarget 7 (28), 44686, 2016 | 29 | 2016 |
| Indoleamine 2, 3-dioxygenase 1 and programmed cell death-ligand 1 co-expression predicts poor pathologic response and recurrence in esophageal squamous cell carcinoma after … S Zhou, L Zhao, Z Liang, S Liu, Y Li, S Liu, H Yang, M Liu, M Xi Cancers 11 (2), 169, 2019 | 28 | 2019 |
| Combination therapy after TACE for hepatocellular carcinoma with macroscopic vascular invasion: stereotactic body radiotherapy versus sorafenib L Shen, M Xi, L Zhao, X Zhang, X Wang, Z Huang, Q Chen, T Zhang, ... Cancers 10 (12), 516, 2018 | 27 | 2018 |
| Sorafenib modulates the radio sensitivity of hepatocellular carcinoma cells in vitro in a schedule-dependent manner Q Li, Y Hu, M Xi, L He, L Zhao, M Liu BMC cancer 12, 1-10, 2012 | 26 | 2012 |
| Role of Caspase 8, Caspase 9 and Bcl-2 polymorphisms in papillary thyroid carcinoma risk in Han Chinese population YX Wang, L Zhao, XY Wang, CM Liu, SG Yu Medical Oncology 29, 2445-2451, 2012 | 26 | 2012 |
| Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial S Liu, L Luo, L Zhao, Y Zhu, H Liu, Q Li, L Cai, Y Hu, B Qiu, L Zhang, ... Nature Communications 12 (1), 4014, 2021 | 25 | 2021 |
| P300 promotes migration, invasion and epithelial-mesenchymal transition in a nasopharyngeal carcinoma cell line ZW Liao, L Zhao, MY Cai, M Xi, LR He, F Yu, TC Zhou, MZ Liu Oncology Letters 13 (2), 763-769, 2017 | 24 | 2017 |
| Low expression of IGFBP-3 predicts poor prognosis in patients with esophageal squamous cell carcinoma L Zhao, LR He, R Zhang, MY Cai, YJ Liao, D Qian, M Xi, YX Zeng, D Xie, ... Medical oncology 29, 2669-2676, 2012 | 24 | 2012 |
Zizhen Feng, MD, PhDYale New Haven health systemVerified email at bpthosp.org
